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Biomimetically designed materials matching the chemical and mechanical properties of tissue 
support higher mesenchymal stem cell (MSC) adhesion. However, directing cell-specific attachment 
and ensuring uniform cell distribution within the interior of 3D biomaterials remain key challenges in 
healing critical sized defects. Previously, a phage display derived MSC-specific peptide 
(DPIYALSWSGMA, DPI) was combined with a mineral binding sequence (VTKHLNQISQSY, VTK) to 
increase the magnitude and specificity of MSC attachment to calcium-phosphate biomaterials in 2D. 
This study investigates how DPI-VTK influences quantity and uniformity of iPS-MSC mediated bone 
and vasculature formation in vivo. There was greater bone formation in vivo when iPS-MSCs were 
transplanted on bone-like mineral (BLM) constructs coated with DPI-VTK compared to VTK (p < 
0.002), uncoated BLM (p <0.037), acellular BLM/DPI-VTK (p <0.003) and acellular BLM controls 
(p<0.01). This study demonstrates, for the first time, the ability of non-native phage-display designed 
peptides to spatially control uniform cell distribution on 3D scaffolds and increase the magnitude 
and uniformity of bone and vasculature formation in vivo. Taken together, the study validates phage 
display as a novel technology platform to engineer non-native peptides with the ability to drive cell 
specific attachment on biomaterials, direct bone regeneration and engineer uniform vasculature in 
vivo.  
1. Introduction 
Mesenchymal stem cells (MSCs) are a promising source for cell-based bone regeneration. [1,2] 
Since their initial discovery in the bone marrow stromal niche, MSCs have been identified in various 
adult and neonatal tissues, including but not limited to adipose tissue, peripheral blood, amniotic 
fluid, and umbilical cord.[3] MSCs can also be derived from embryonic and induced pluripotent stem 
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cell (iPS) lineages.[4–6] Induced pluripotent stem cell derived MSCs are of clinical interest because 
they provide a more continuous and uniform supply of cells compared to primary MSCs and avoid 
concerns that exist with embryonic stem cells.   
Bioresorbable natural and synthetic polymers, calcium phosphates and sulfates and 
polymer-mineral composite materials are frequently used as scaffolds to deliver cells to bone 
defects.[7,8] Tunable mechanical properties, controlled degradation rates, and scalable  
manufacturing afford synthetic polymers significant advantages over naturally derived polymers.[9–11] 
Incorporating a mineral component provides additional mechanical support and recapitulates a 
chemical microenvironment conducive to osteogenecity.[12,13] Amongst the various methods of 
incorporating a mineral component onto a biomaterial, growth of a mineral layer by immersion in 
simulated body fluid (SBF) containing the ionic concentrations of blood plasma under physiological 
pH is a promising strategy because it avoids high temperature and pressure processing.[13–15]  The 
bone-like mineral (BLM) layer resulting from SBF immersion has been characterized in detail and is 
compositionally and microstructurally similar to bone, thereby improving osteoconductivity in vitro 
and bone formation in vivo.[11,12,16] Nanoscale morphology, crystallinity, and compositional 
characteristics of the mineral surface increase adsorption of cell-adhesive serum proteins like 
fibronectin and vitronectin which subsequently increase osteoconduction.[17–19] However, the 
chemical and physical properties of the mineral alone are insufficient to selectively adhere cells.    
Due to the limitations of covalently tethering instructive molecules to mineral substrates, 
mineral binding ECM proteins and peptide domains have been used for presentation of cell adhesive 
peptides to imorganic biomaterials.[20,21]  For example, the glutamic acid repeat motif (E7) in bone 
sialoprotein was combined with RGD to increase adsorption of RGD to BLM and promote 
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osteoconductivity.[22] Although the RGD-E7 peptide improves osteoconductivity on mineralized 
biomaterials in vitro, it inhibits osseointegration in vivo.[17] The varied successes with RGD and other 
integrin binding peptides prompted the identification of cell specific peptides that can selectively 
bind bone forming cell populations from a heterogeneous stem or progenitor source.  
To meet the objective of selectively binding MSCs to mineralized biomaterials, we used 
phage display coupled with bioinformatic approaches and in vitro screening techniques to identify 
MSC-specific [DPIYALSWSGMA, DPI] and apatite-specific [VTKHLNQISQSY, VTK] sequences which 
were combined into a dual peptide [GGDPIYALSWSGMAGGGSVTKHLNQISQSY, DPI-VTK] for cell 
specific adhesion to mineralized biomaterials.[23,24] DPI-VTK efficiently targets apatite and increases 
adhesion strength and specificity to human and murine MSCs and induced pluripotent stem cell 
derived mesenchymal stem cells (iPS-MSCs).[25] Moreover, DPI-VTK improves spreading and 
proliferation while supporting differentiation on dual peptide coated constructs compared to non-
peptide coated controls. These findings suggest a role for MSC driven bone formation in vivo by the 
DPI-VTK peptide.   
In addition to increasing the quantity of tissue, increasing the uniformity of regenerated 
tissue throughout a defect site is an important design goal. In this study, we hypothesize that 
increasing iPS-MSC attachment and uniformity of distribution in 3D using phage-derived peptides 
will lead to increased quantity and uniformity of regenerated bone and vasculature in vivo.  This 
hypothesis was tested by functionalizing mineralized PLGA scaffolds with the DPI-VTK peptide and 
comparing outcomes to BLM controls, RGD-VTK, and P15 coated BLM. The ubiquitous cell binding 
domain RGD was combined with the mineral binding domain VTK to be used as a dual-peptide 
positive control (RGD-VTK) for in vitro characterization (Table 1). P15 peptide, a component of Pep-
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Gen P15-BGS (Dentsply Implants, CA) currently available as a bone graft substitute for void filling and 
augmentation, was used as an in vivo positive control.[26–28]  
2. Results 
2.1 Mineral Distribution on BLM Scaffolds 
Spatially continuous mineral coverage on porous PLGA scaffolds was achieved across all 
groups. Average mineral volume fractions (MV%) for all treatment groups were 16.5±3.8%. Filtration 
of SBF resulted in mineralization through the thickness of each scaffold (Figure 1, a-f).  There were 
no significant differences in MV% between regions, except for  a greater fraction of mineral in the 
interior region (shell 5) compared to the exterior region (shells 1 and 2) (Figure 1g, p < 0.001, n=10). 
Greater mineralization in the interior region may arise from increased turbulent flow conditions, and 
early nucleation within the interior of the scaffold pores. Regardless, there was no observable pore 
occlusion that limits transport and vascularization.  
2.2 Delivery of Peptides to Mineral Scaffolds 
Peptide adsorption on mineralized scaffolds was not different between VTK, DPI-VTK and 
RGD-VTK groups (Figure 2a, n=6). Peptide adsorption on 3D scaffolds was uniform for each peptide 
and uniform within each region across peptides, with the exception of more VTK than RGD-VTK in 
the outermost section (Figure 2c, p <0.02). The fraction of adsorbed peptide was not different within 
peptide groups (Figure 2c).  
2.3 Cell Seeding Efficiency on Peptide-Laden Scaffolds 
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There was more efficient iPS-MSC seeding on VTK (p<0.04), DPI-VTK (p<0.002), RGD-VTK 
(p<0.001), and serum coated BLM (p<0.001) compared to serum-free BLM control groups (Figure 
3a). RGD-VTK exhibited higher seeding efficiency than BLM (p<0.001), VTK (p<0.001), and DPI-VTK 
(p<0.01). All peptide groups demonstrated uniform cell distribution across radial sections, except the 
percent of cells adherent to the outermost section on VTK coated scaffolds was greater than the 
middle and inner-most sections (Figure 3b; p<0.001). Moreover, there was a greater fraction of cells 
adherent to the innermost region of scaffolds coated with DPI-VTK peptide compared to BLM 
(p<0.001), VTK (0.01) and RGD-VTK (p<0.001).  
2.4 MSC Differentiation on Peptide Coated BLM In Vitro 
There was greater Runx2 expression on DPI-VTK compared to BLM controls (p < 0.023, Figure 4a), 
whereas expression on RGD-VTK and P15 exhibited no significant difference.  
OSX exhibited greater expression on DPI-VTK(p <0.05) and RGD-VTK (p < 0.001), on day 14 compared 
to day 3. There was greater OSX expression on RGD-VTK (p < 0.001) on day 14 (Figure 4b) compared 
to BLM. Similarly, across all peptide groups, ALP expression (Figure 4c) was greater on days 14 and 
21 compared to day 10 (p < 0.001). ALP expression peaked earlier on DPI-VTK(day 14) compared to 
RGD-VTK(day 21). There was higher ALP expression on DPI-VTK on day 14 (p<0.01) compared to BLM 
controls. There was higher OCN expression on DPI-VTK at day 14 (Figure 4d) compared to BLM 
controls(p<0.001), RGD-VTK(p<0.001), and DPI-VTK on day 10 (p < 0.001).  
2.5 Competitive MSC Binding Assays   
Competitive binding assays were conducted to identify potential iPS-MSC surface receptors involved 
in binding cells to DPI-VTK. Soluble RGD or integrin antibodies compete with peptides bound to 
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biomaterial surfaces for cell surface integrins. Soluble RGD and specific integrin antibodies were 
added in suspension to reach equilibrium with MSC integrin receptors and seeded on DPI-VTK or 
RGD-VTK coated materials to verify competition with the same integrin binding receptors.  Cell 
attachment was significantly greater in the absence of soluble RGD compared to all concentrations 
for both DPI-VTK and RGD-VTK (Figure 5a, p<0.001). Cell attachment was significantly greater in the 
presence of 0.01mM soluble RGD compared to 0.1 or 1mM RGD (p < 0.02). There was greater cell 
spreading in the absence of soluble RGD on both DPI-VTK and RGD-VTK (Figure 5b). There were 
significantly less adherent cells in the presence of RGD binding integrin subunits compared to no 
integrin blocking controls and blocking the collagen binding integrin 21 (p < 0.001) on both DPI-
VTK and RGD-VTK coated BLM films (Figure 5c). The adherent cell fraction on DPI-VTK in the 
presence of αV, α5, and β3 was significantly greater compared to RGD-VTK, indicating a weaker 
interaction between these domains and DPI peptide compared to RGD.  
2.6 Bone Volume Fraction and Distribution In-Vivo 
MicroCT images reveal, qualitatively, greater bone formation on scaffolds with DPI-VTK and 
P15 compared to acellular scaffolds without peptide, acellular scaffolds with peptide, cellular 
scffolds without peptide and cellular scaffolds with just the mineral binding peptide (Figure 6a). 
Scaffolds coated with both DPI-VTK and P15 exhibited shell formation characteristic of ectopically 
reconstructed ossicles. Quantitatively, there was a significantly greater BVF in constructs coated with 
DPI-VTK compared to VTK (p < 0.002), BLM (p <0.037), acellular DPI-VTK (p <0.003) and acellular BLM 
controls (Figure 6b, p < 0.003). P15 coated constructs had a significantly greater BVF than BLM (p 
<0.05) and acellular BLM (p <0.005). There were noticeable differences between VTK coated 
constructs and uncoated and acellular controls but statistically insignificant due to large variance. 
   
 
This article is protected by copyright. All rights reserved. 
8 
 
Rendered MicroCT images of concentric shells of regenerated bone (Figure 7a-e) revealed 
greater bone formation towards the peripheral sections compared to interior sections. DPI-VTK 
coated constructs had a significantly greater fraction of bone in section 1 compared to section 5 
(p<0.002) and section 4 (p<0.003), as well as a greater fraction of bone in section 2 compared to 
section 5 (p<0.005) and section 4 (p<0.008) (Figure 7f).  Similarly, P15 coated constructs had a 
greater fraction of bone in section 1 compared to section 5 (p<0.004) and section 4 (p<0.005), as 
well as a greater fraction of bone in section 2 compared to section 5 (p<0.015) and section 4 
(p<0.019). VTK coated constructs had a greater fraction of bone in section 2 compared to sections 4 
(p<0.004) and 5 (p <0.026). 
2.7 Histology of Regenerated Bone 
There was greater bone formation on DPI-VTK and P15 coated constructs compared to VTK 
and BLM constructs (Figure 8 a-h). Cells seeded on BLM with VTK led to some bone formation 
surrounding scaffold pores (p), however the DPI-VTK and P15-laden constructs exhibited more 
robust bone formation and were relatively devoid of pores (p) and struts (t).  Ossicles regenerated 
from BLM and VTK coated scaffolds look compressed and elongated compared to pre-transplanted 
scaffolds, whereas bone regenerated from DPI-VTK and P15-coated constructs was larger than the 
originally transplanted constructs, which is consistent with the quantitative BV data. Regenerated 
bone from DPI-VTK and P15 also demonstrated greater vascularization (h) and cellularity (c) 
compared to VTK coated and BLM constructs. Bone scores also indicate greater bone formation on 
DPI-VTK and P-15 compared to VTK and BLM (Figure 8i; p <0.001).  Vascular scores indicate a greater 
hematopoetic population and vascular structures on DPI-VTK and P15 compared to BLM and VTK 
constructs (Figure 8j; p<0.001) There were no differences in bone score within different sections of 
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scaffolds for each peptide group, but across sections (Figure 8k), DPI-VTK and P15 exhibited greater 
bone scores compared to VTK and BLM (p <0.001).  Similarly, DPI-VTK and P15 exhibited higher 
vascular scores compared to VTK and BLM (Figure 8l; p<0.001), but no differences in scores were 
observed within sections.  
3. Discussion 
Phage-display, a techonology commonly used in the design of pharmecutical biologics, is 
relatively new to the field of regenerative medicine. This powerful bacteriophage tool, combined 
with computational bioinformatics, provides a novel technology platform to design cell instructive 
biomaterials through surface engineering. We have demonstrated the significance of utilizing phage-
display to develop a non-obvious, modular peptide design strategy and show equivalence in bone 
formation to current clinical bone augmentation therapeutics, P15, which is nased on already known 
ECM protein sequences.  
iPS-MSCs transplanted onto DPI-VTK coated mineralized biomaterials increased bone 
formation in-vivo compared to non-peptide coated, VTK-coated and acellular controls (Figure 6,7). 
Moreover, bone formed by cells transplanted on DPI-VTK coated constructs exhibited increased 
cellularity and vascularization compared to uncoated, VTK and acellular controls (Figure 8). Although 
seeding efficiency was greater on DPI-VTK and serum-coated BLM compared to VTK (Figure 3a, p < 
0.05), the DPI peptide promotes cell specific attachment of MSC populations compared to RGD-
VTK.[24] There was also a greater percentage of iPS-MSCs within the innermost region of DPI-VTK 
coated constructs compared to RGD-VTK, VTK, and BLM (Figure 3), indicating greater migration into 
the interior of the scaffold.  Peptides containing the mineral specific sequence, VTK (VTK, DPI-VTK, 
RGD-VTK) demonstrated affinity to BLM coated scaffolds(Figure 2a).  
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 Micro-CT cannot distinguish bone from Ca/P biomaterials.  Thus, for mineralized 
biomaterials, the initial mineral volume is commonly subtracted from the final bone volume to 
calculate regenerated bone volume.  However, these calculations assume that the mineralized 
substrates do not resorb over the course of the transplantation in-vivo.  Coating porous scaffolds 
with BLM nucleated from 2x SBF results in a rapidly dissolving Ca/P shell that is almost completely 
resorbed, as evidenced by the negligible fraction (2-3% BVF) in the acellular controls (Figure 6a) 
compared with the starting mineral volume fraction of 16.5% (Figure 1). Cells transplanted onto BLM 
formed from 2x SBF, resulted in poor bone formation compared to previous studies utilizing mineral 
precipitated from 1x SBF. Moreover, a thrombin-fibrin clot is typically used to provide further 
retention of cells within a Ca-P construct. Using a fibrin clot would have prohibited the direct testing 
of the peptide, and inability to use a fibrin clot could have resulted in poor bone formation in BLM-
coated materials compared to previous studies.   Although there were no differences in total 
volume, bone volume fraction or bone scores of regenerated bone between P15 and DPI-VTK coated 
cellular constructs, further engineering the dual peptide by modifying the spacer, arrangement of 
the sequence or incorporating post translational modifications to increase cell specificity could lead 
to greater bone formation than the clinically derived P15 peptide.  
Cell-seeded constructs, especially those containing MSCs, can drive vascularization through 
secretion of pro-angiogenic factors contributing to hematopoesis which concomitantly drives greater 
bone formation[1,29]. Hematopoetic regions were evident across all cell-transplanted treatment 
groups and greater cell numbers were observed within constructs coated with DPI-VTK and the 
positive control P-15 (Figure 8). A shell of bone at the exterior of the scaffold, resulting in a spatial 
gradient in bone formation, was evident in both P15 and DPI-VTK coated constructs (Figure 6). A 
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shell is commonly formed in an ectopic model.[30–32] The subcutaneous environment is physically and 
temporally limited by the ability to form deeply penetrating vascular networks before cell mediated 
mineralization causes pore occlusion and isolation of the interior regions.[33] Both bone and vascular 
regions were present throughout constructs containing DPI-VTK and P15 (Figure 8). In DPI-VTK 
coated materials, vascularization was equivalent in all regions and not compromised in the interior.  
Bony spicules within the center regions of both DPI-VTK coated and P15 coated constructs exhibited 
thick cellularized sections which is inconsistent with latent mineral from pre-implanted sources. 
Despite the shell formation, DPI-VTK promoted moderate bone formation penetrating 60% of the 
scaffold interior.  
Early expression of Runx2 and OSX followed by increased ALP expression compared 
to controls indicate more osteogenic differentiation of MSCs on DPI-VTK and RGD-VTK 
compared to BLM (Figure 4). The promotion of earlier osteogenic differentiation of MSCs by 
DPI-VTK in vitro suggests a cell instructive role. For instance, growth and differentiation of 
transplanted MSCs results in greater cell secreted factors that can drive bone regeneration. 
The increased expression of early and late stage osteogenic differentiation markers in vitro 
and improved bone formation in-vivo on DPI-VTK coated mineral scaffolds suggest peptide 
mediated mechanotransductive pathways could be driving greater bone formation in vivo.  
MSCs adhere with more uniform fibrillar cell substrate contacts on bone-like mineral 
surfaces compared to more peripheral focal adhesion contacts on non-coated surfaces[19]. 
Peptides strongly adsorbed to the substrate may further increase the formation of these 
strong fibrillar contacts thereby driving mechanotransductive pathways. Various osteogenic 
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pathways are activated through focal or fibrillar contacts at the cell-substrate interface 
leading to kinase activation and osteogenic signal transduction at these adhesion sites[34,35]. 
The phage display derived cell binding sequence, DPI, could be selective towards a profile of 
integrins or cell adhesion molecules driving strong cell substrate interactions which may be 
driving greater bone formation. 
Competition with soluble RGD indicated the role of RGD binding integrins in mediating MSC-
DPI interactions (Figure 5a). Furthermore, inhibition of cell spreading on DPI-VTK in the presence of 
soluble RGD (Figure 5b) demonstrated the requirement of RGD binding integrins in mediating cell 
spreading on DPI-VTK.  Competition with RGD-binding integrin antibodies α5, β1, αV, β3, β5 further 
confirmed the role of RGD-binding integrins in mediating DPI-VTK cell attachment (Figure 5c). The 
differences in adherent cell fractions between DPI-VTK and RGD-VTK in the presence of integrin 
antibodies can be attributed to either different affinities or conformational flexibility in binding 
different integrin domains. The promiscuity of DPI-VTK adhesion to a panel of RGD binding integrins 
may be attributed to phage display selection of cell surface targets that are highly expressed. MSCs 
express a distinct profile of integrins at distinct differentiation times.[36–38] Therefore, these phage 
derived peptides may be adhering to one or more integrin targets in addition to other cell adhesive 
molecules thereby driving greater MSC specific adhesion strength as previously observed and 
contributing towards the increase in bone formation.   
The improvement in in vivo osteogenic potential provided by DPI-VTK warrants further 
investigation towards the mechanism of action. Future studies to elucidate specific cell binding 
targets in addition to conformational regulation of DPI when present with the material-binding VTK 
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sequence can further improve the osteogenic potential of these phage derived peptides. As tissue 
engineering shifts from developing technologies to meet general clinical challenges to addressing 
more focused clinical applications, there will be an increased need for delivering cell specific cues to 
material surfaces with defined surface chemistries. [23,39] Combinatorial phage display is a powerful 
technology platform to enable focused cell based tissue regeneration through the discovery of cell 
specific and material specific peptide sequences. 
4. Conclusion 
Combinatorial phage display identified a bioactive peptide sequence that increases osteogenesis and 
vascularization on mineralized 3D biomaterials in vivo. In addition to improving cell attachment to 
mineral surfaces, this dual peptide improved ostogenic differentiation and attachment to integrin 
binding domains implicated in osteogenic differentiation pathways. Constructs containing DPI-VTK 
formed more bone, contained more cells, and exhibited greater and more uniform vascularization 
compared to acellular controls, non-peptide coated BLM and VTK coated BLM. Modular design of 
non-native peptides using combinatorial phage-display catalyzed bone and vasculature formation 
equivalent to the clinical control, collagen-based P15 peptide, and further mechanistic inquiries can 
guide and refine the peptide driven cell instruction towards increased quality and quantity of 
regenerated  bone and vasculature. 
5. Experimental Section 
Mineralized Scaffold and Film Fabrication: Polylactic-co-glycolic acid (PLGA 85:15, Lakeshore 
Biomaterials) was solubilized in chloroform at 5%w/v. NaCl was sieved to 250-425µm and packed 
into 5mm diameter wells in a Delrin® mold. PLGA-chloroform solution was added to each well of the 
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Delrin® mold which was then covered and dried for 36hrs. The mold was transferred to a vacuum 
chamber for 5 days and NaCl was leached in double-distilled water (ddH2O) for 36hrs with 
intermittent fluid changes. Porous scaffolds were etched in 0.5M sodium hydroxide under slight 
agitation and rinsed twice in ddH2O.  Scaffolds were mineralized by filtration of simulated body fluid 
(SBF) through interconnected pores as described.[40] SBF (1x)  contains 141 mM NaCl, 4.0 mM KCl, 
0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2•2H2O,and 2.0 mM KH2PO4.
[41]  2x SBF 
and 4x SBF solutions titrated to pH 6.4 with 1M NaOH were sterile filtered using a 0.22µm filter and 
0.005% sodium azide was added to prevent bacterial contamination. A Delrin® mold containing 
scaffolds was attached to the actuator of an Instron 8521 servo-hydraulic system. The mold was 
lowered into a base containing a volume of pre-warmed 4x SBF (37oC) to fully submerge all scaffolds 
during the course of mineralization. The mold was cycled at an amplitude of 25.4mm at 0.011Hz.  
The 4x SBF was changed every 6 hours the first day and replaced with 2x SBF which was changed 
every 12 hours on days 2-5. Solution temperature in the base was maintained at 37oC using a 
heating sleeve connected to a thermocouple and temperature controller (Extech Instruments). 
Mineralized scaffolds (5mm diameter x 2 mm thickness) were carefully detached from the mold, 
rinsed in ddH2O for 12 hrs, air-dried in a biosafety cabinet for 12 hrs and stored in a desiccator.  
Bone-like mineral films were used to characterize cell differentiation in vitro and competitive 
inhibition of cell binding to peptide coated surfaces. Mineral films were prepared by immersing PLGA 
thin films in simulated body fluid to precipitate carbonated apatite with plate like nanofeatures. A 
5% w/v 85:15 polylactic-co-glycolic acid (PLGA, Lakeshore Biomaterials)-chloroform solution was cast 
on 15mm diameter glass slides. The PLGA films were etched in 0.5M NaOH and immersed in 
modified simulated body fluid (mSBF) for 5 days at 37°C with fluid changes every 24 hrs. The mSBF 
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was made by dissolving the following reagents in Millipore water at 25°C and titrating to pH 6.8 
using NaOH: 141 mM NaCl, 4.0 mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM 
CaCl2•2H2O, and 2.0 mM KH2PO4.  
Peptide Synthesis: Peptides (Table 1) were synthesized at the University of Michigan peptide core. All 
peptides were chemically synthesized using solid phase synthesis and protective chemistry. HPLC 
was used to verify > 95% purity. Peptides were stored at -20oC until further use.  
Peptide Loading on Mineralized Scaffolds: Scaffolds pre-wet overnight in ddH2O were sterilized, 
transferred to a new micro-plate, and incubated in Trizma buffer for 4hrs at 37oC. Peptides were 
weighed, dissolved in sterile ddH2O, and diluted in Trizma buffer pH 7.4. Scaffolds were immersed in 
peptide solution (100µg/mL) and gently agitated for 3hrs at 37oC. Pierce BCA assay (Thermo-Fisher 
Scientific Inc.) was used to determine total peptide amount on scaffolds (n=6) and compared to a 
standard curve (1-200 µg mL-1).  Peptide distribution on scaffolds was assessed using fluorescein 
isothiocyanote (FITC) tagged peptides (n=6).  
Cell Culture and Seeding on Peptide Coated Scaffolds: Mesenchymal stem cells derived from induced 
pluripotent stem cells (iPS-MSCs) were a generous gift from Dr. Paul Krebsbach and Dr. Luis Villa. 
These cells were verified for osteogenic differentiation and bone forming potential in vivo.[5] iPS-
MSCs were cultured in (α-MEM), 10% FBS, antibiotics, 200mM L-glutamine, and 10mM non-essential 
amino acids. iPS-MSCs (passage 5) were expanded twice when they reached 80-90% confluence 
before transplantation. Growth media was replaced every 2-3 days and switched to osteogenic 
media and supplemented with osteogenic factors (10-8M Dexamethasone, 2-5mM β-
glycerophosphate, 10-4 M ascorbic acid) for 7 days prior to transplantation. Peptide-coated scaffolds 
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were placed into 100uL PCR tubes. Confluent iPS-MSCs (passage 7) were trypsinized and suspended 
in either serum-free or complete media in a 20µL volume containing 50,000 cells. The cell 
suspension was seeded into each scaffold for 3hrs at 5% CO2 and 37
oC.  
Peptide and Cell Distribution on Mineralized Scaffolds: Fluorescently tagged peptide coated scaffolds 
were paper-embedded in cryosection molds in freezing media (OCT, Tissue Tek) on a bed of dry ice 
and acetone.[42] Cell-seeded scaffolds (n=6/group) were fixed in 10% phosphate buffered formalin 
and paper embedded in cryosection molds in freezing media (OCT, Tissue Tek) on a bed of dry ice 
and acetone.[42]  A Leica cryostat was used to make five 200µm thick sections through the thickness 
of each scaffold. Sections were mounted in Vectashield (Vector Laboratories) and imaged using a 
Nikon Ti-Eclipse confocal microscope. Sections were imaged at constant intensity and gain settings 
across all samples using a 4x objective that incorporated the entire section in the field of view.[43] 
Edges were clipped to limit artifact and 40 images were acquired for each section at 5µm intervals. 
Image J software (NIH) was used to stack 40 images projected in the Z direction. A modified 
concentric circle algorithm was used to measure fluorescence intensity in the corresponding circle 
within each section - outermost circle for section 1 to innermost circle for section 5 (Figure 2b).  
MSC Differentiation:  Mineralized films were held in place with Teflon O-rings for differentiation 
assays to prevent films from floating. Films were incubated in peptide solution(100 μg mL-1) for 3 
hrs. iPS-MSCs were plated (15,000 cells cm-2) and grown to confluence until differentiated in 
complete media containing osteogenic factors (10-8M Dexamethasone, 2-5mM β-glycerophosphate, 
10-4 M ascorbic acid). Cells were differentiated for 0, 3, 7, 10, 14, 21, 28 days and collected (n=3) in 
TRIZOL® (ThermoFisher Scientific). Cells were homogenized in TRIZOL®, phase-separated in 
chloroform, and RNA was precipitated in 500μL isopropanol, washed in 80% ethanol, dried and 
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dissolved in RNA grade double distilled water (Milipore) at 70oC. The amount of RNA was measured 
using a spectrophotometer and 1g was used for reverse transcription using SuperScript II reagents 
(ThermoFisher Scientific). TaqMan® Universal PCR Master Mix and Taqman primer probes RUNX2 
(Hs01047973_m1), OSX(Hs01866874_s1), ALP(Hs03674916_s1), OCN(Hs01587814_g1) were used 
for qRT-PCR reactions. Cycle threshold (CT) values for each gene of interest(GOI) were normalized to 
GAPDH expression to attain ΔCT and day zero values were used as a baseline to attain ΔΔCT.
[44] Fold 
changes (2- ΔΔCT) are depicted in Figure 4, delta-delta CT (ΔΔCT)  values were used for statistical 
analysis.   
Competitive Attachment of MSCs to Peptides: iPS-MSCs were incubated in the presence of 
competing antibodies αV, α5, β1, β3, β5, α2β1 (Cell Signaling Technology, 10μg mL
-1) or soluble RGD (1, 
0.1, 0.01mM) for 10 min at 37oC under slight agitation (n=6). [45–47] Mineralized films were attached 
to the bottom of 24 well plates with sticky tabs. Cells suspended in serum-free media with soluble 
RGD or integrin antibodies were subsequently added to peptide-coated mineral films (100µg mL-1) 
for 3 hours in the presence of inhibitors. Adherent cells were measured using a WST-1 assay and a 
standard curve from 100-10,000 cells. Cells were subsequently fixed, F-actin was stained with 
Rhodhamine-Pholloidin, and nuclei were stained with DAPI.  Fluorescent images were acquired using 
a Nikon Ti-Eclipse confocal microscope.  
Transplantation of Cell-Seeded Constructs: Peptide coated scaffolds and uncoated mineralized 
control scaffolds were placed in PCR tubes and statically seeded in a 20µL volume of complete media 
containing 3 x 106 cells on each construct for 3 hours. This micromass seeding method was used to 
improve seeding efficiency. Cell seeded scaffolds (n=6) were stored on ice prior to transplantation.  
Acellular mineralized scaffolds and acellular mineralized scaffolds coated with DPI-VTK were 
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included as controls (n=4). All surgical procedures were performed in accordance with NIH guidelines 
for the care and use of laboratory animals (NIH Publication #85-23 Rev. 1985) and the University of 
Michigan’s Committee on Use and Care of Animals. Female nude mice (NIH-Lystbg-JFoxn1nuBtkxid, 
Charles Rivers) between 25-30g were anesthetized with isoflurane in O2 (5% induction and 2% 
maintenance at 1mL min-1).  A midline longitudinal incision was made on the back of each mouse 
and 4 pockets (2 on each side) were made in the subcutaneous tissue beneath the dorsal skin.  
Scaffolds were randomly placed into each pocket and the incision was closed with surgical staples. 
Animals were sacrificed 8 weeks postoperatively and transplants were harvested.  
Microcomputed Tomography: Mineralized scaffolds (prior to cell seeding and transplantation) and 
ossicles of regenerated bone were assessed using Scanco μCT 100 at 10 μm voxel size at 10 μm slice 
increments. Bones were fixed in 4% phosphate buffered formalin prior to imaging. MicroCT scans 
were obtained at 70kV, 114 A using a 0.5 Al filter. Reconstructed images of all scaffolds and bones 
were analyzed using the Scanco μCT evaluation tool to calculate mineral volume fractions (MVF, 
n=10) and bone volume fraction(BVF, n=6) respectively. Reconstructed images were rendered in 
(MicroView, Parallax Innovations Inc) using the isosurface tool at a threshold of 1000 with the 
smoothing filter and a surface quality factor of 0.51 . A custom volumetric shrinkage algorithm was 
used to generate five concentric volumetric shells each 20% smaller than the previous volume. Total 
volumes and volume fractions were calculated for each shell and compared across the five 
volumetric shells to examine mineral and bone distribution from the exterior toward the interior of 
the scaffold. Mineralized scaffolds were distributed by MVF across control and treatment groups so 
that there were no initial statistical differences in mean MVF amongst groups. Bone volume fractions 
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are presented unadjusted by initial mineral volume fractions because a majority of initially 
implanted mineral was resorbed 8 weeks post-implantation in acellular controls.  
Histology and Histomorphometry: Ossicles were decalcified in 10% EDTA. Transplants (n=5) were 
sectioned through the midline, paraffin embedded, and 5µm thick triplicate sections were made of 3 
ossicle regions progressing from the interior to the periphery. Sections were subsequently 
deparaffinized, hydrated, and stained with hematoxylin and eosin. A 20x field of view was used to 
scan sections and assess bone coverage.  Totals for each ossicle region were averaged. Sections were 
scored for bone and vasculature using parameters outlined in Table 2.[48,49]  
Statistical Analysis: All data are presented as mean ± standard deviation (SD).  Statistical analysis was 
conducted using Sigmaplot 13.0 (Systat Software Inc. Chicago, IL). One-way ANOVA on ranks using a 
Tukey test for pairwise comparison was used to compare initial mineral fraction (n=10), peptide 
adsorption (n=6), cell seeding (n=6), bone score (n=5) and vascular score (n=5) across treatment 
groups. One-Way ANOVA on ranks with Dunn test for pairwise comparisons was used to assess bone 
volume fractions(n=6). Two-Way ANOVA on ranks using Tukey test for pairwise comparisons was 
used to assess peptide (n=6), cell (n=6), mineral (n=10) and bone volume distribution (n=6) as a 
function of peptide and location. Tukey post-hoc pairwise comparisons were also used to analyze 
competitive inhibition (n=6) and cell differentiation (n=3). Data was considered significant if p < 0,05. 
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Figure 1: Morphology and distribution of bone-like mineral precipitated into the pores of PLGA 
scaffolds. Representative MicroCT image of mineralized scaffold rendered in MicroView®(A). 
Representative images of mineral distribution in volumetric shells progressing from the outermost to 
innermost regions of the scaffold (B-F). Fraction of mineral volume from the outermost to the 
innermost volumetric shell of the scaffolds (G).  * indicates significant difference from sections 1 and 
2 (p<0.001, n = 10).  
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Figure 2. Peptide adsorption and distribution on mineralized PLGA Scaffolds(n=6). (A) There was no 
significant difference between VTK, DPI-VTK and RGD-VTK (B) Schematic and representative images 
of DPI-VTK distribution depicting relative position of each cryosection (1-5 in Z direction) and 
sampled region (a-e radially) within corresponding sections. Each image is a composite stack of 40 
images projected in the Z direction based on average intensity (scale bar 0.5mm). (C) Uniform 
distribution of adsorbed peptide (n=6) across all groups was analyzed using Image J (NIH) software 
with a customized concentric circle algorithm. * indicates significant difference from Section 1 of 
RGD-VTK (p <0.02).   
 
   
 
This article is protected by copyright. All rights reserved. 
26 
 
 
Figure 3. Cell Seeding efficiency and distribution on peptide coated scaffolds(n=6). A) Seeding 
efficiency on peptide coated scaffolds based on histomorphometric analysis. *** indicates significant 
difference from DPI-VTK (p<0.01), VTK (p<0.001), and BLM (p<0.001). ** indicates significant 
difference from VTK (p <0.05) and BLM (p <0.002) groups. * indicates significant difference from 
BLM (p<0.04) group. B) Fraction of adherent cells by spatial location indicating higher cell fraction 
bound to VTK in section 1 compared to BLM (*, p<0.02). ** indicates higher cell fraction bound to 
DPI-VTK in section 5 compared to BLM (p<0.001), VTK (p<0.1) and RGD-VTK (p<0.001).   
   
 
This article is protected by copyright. All rights reserved. 
27 
 
 
 
Figure 4. Differentiation of iPS-MSCs on bone like mineral and peptide coated bone like mineral 
characterized by gene expression levels of early(RUNX2, OCN) and late(ALP, OCN) osteogenic gene 
epression markers(n=3). A) Relative gene expression of osteogenic transcription factors Runx2 * 
significant difference from BLM day 14 (p < 0.023, n = 3), B) Relative gene expression of osteogenic 
transcription factors and Osterix(OSX) * from day 3(p<0.001, n=3),  significant difference from BLM 
^(p < 0.001, n = 3), #(p < 0.05, n = 3). C) Relative expression of genes regulating ALP - grey bars 
indicate significant difference of groups from day 10 p<0.001), * indicates significant difference from 
DPI-VTK and BLM on day 14(p<0.001, n=3) ^significant difference from BLM(p<0.01, n=3)  D), 
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Relative expression of genes regulating OCN * greater than BLM controls, RGD-VTK and day 10(p < 
0.001, n=3)  
 
 
 
 
Figure 5. iPS-MSC competition with soluble integrin binding competitors(n=6). A) Fraction 
of adherent cells on peptide coated BLM in the presence of soluble RGD normalized to no 
soluble competitors. * denotes significant difference from other concentrations of soluble 
RGD within peptide group (p<0.01). ** denotes significant difference from the 0.1 and 
1mM concentrations (p<0.02) within each peptide group. B) Representative images at 40x 
of MSCs on DPI-VTK and RGD-VTK coated substrates in the presence and absence of 
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soluble RGD. Nuclei are stained with DAPI and F-actin is stained with rhodhamine-
pholloidin (scale bars 5 µm). C) Fraction of adherent cells on peptide coated BLM in the 
presence of RGD integrin binding receptors and a Col1 binding receptor normalized to 
absence of soluble competitors. * denotes difference from RGD binding integrins (p 
<0.001). Bars denote difference from RGD-VTK within same soluble treatment group (p 
<0.05). 
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Figure 6. Bone volume fractions of ectopically regenerated bone 8 weeks post iPS-MSC 
transplantation (n=6). Representative rendered MicroView® images of bone regenerated with A) 
acellular bone-like mineral (BLM), acellular BLM containing DPI-VTK, BLM with iPS-MSCs, BLM 
containing VTK with iPS-MSCs, BLM containing DPI-VTK with iPS-MSCs, P15 coated BLM constructs 
with iPS-MSCs (scale bar=1mm). B) Bone volume fractions from MicroCT analysis indicate 
significantly greater bone formation in scaffolds with DPI-VTK and P15 compared to VTK, BLM, DPI-
VTK acellular and BLM acellular controls. * indicates a significant difference from BLM and acellular 
BLM (p <0.001). ** indicates a significant difference from VTK (p < 0.001), BLM (p < 0.001), acellular 
DPI-VTK (p < 0.001) and acellular BLM controls (p < 0.001). 
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Figure 7. Distribution of regenerated bone 8 weeks post iPS-MSC transplantation (n=6). A-E) 
Representative images of concentric volumetric shells of bone engineered on bone-like mineral 
coated with phage-derived peptide DPI-VTK progressing from the outermost to innermost region of 
regenerated bone. F) Fraction of total bone by peptide revealing significantly greater fraction of 
bone towards the periphery compared to the interior regions in peptide groups. * indicates 
significant difference from sections 4 and 5. 
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Figure 8. Histological staining and bone quality scoring of regenerated bone 8 weeks post 
transplantation(n=5). A-D) Representative low magnification images of cross sections through the 
center of ossicles, indicating overall degree of bone formation in the interior of the constructs (scale 
bar 500µm). E-H) High Magnification images of cross sections through the center of ossicles 
indicating increased bone formation, vascularization, and cellularity on DPI-VTK and P15 compared 
to VTK and BLM. (b) indicates bone, (h) indicates hematopoesis, (c) indicates greater density of cells, 
(p) indicates pores, (t) indicate scaffold struts replaced by tissue (scale bars 100µm). I) Bone score 
based on bone coverage. * indicates significant differences from BLM and VTK (p <0.001).  J) 
Vascular score by peptide group. * indicates significant differences from BLM and VTK (p <0.001). K) 
Bone score by section across peptide groups. * indicates significant difference from BLM and VTK 
(p<0.001). L) Vascular score by section across peptide groups. * indicates significant difference from 
BLM and VTK (p<0.001).  
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Table 1. Peptide Properties 
Peptide Sequence Description 
MW 
(g/mol) 
Net 
Charge 
Acidic 
residues 
VTK VTKHLNQISQSY 
Phage derived mineral binding 
sequence 
 
 
1417.59 
 
1 2 
DPI-
VTK 
GGDPIYALSWS
GMAGGGSVTKH
LNQISQSY 
Dual functioning peptide 
containing phage derived cell 
and mineral binding sequences 
 
3025.35 
 
0 5 
RGD-
VTK 
GGRGDGGGSV
TKHLNQISQSY 
Dual functioning peptide containing 
cell binding control sequence and 
phage derived mineral binding 
sequence 
2061.20 
 
1 3 
P15 
GTPGPQGIAGQ
RGVV [23] 
Col1a1 derived cell and mineral 
binding peptide for in vivo control 
 
1393.57 
 
1 0 
 
Table 2. Histological Scoring Parameters 
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Non-native peptides derived from a combinatorial phage display are engineered to increase iPS-MSC 
attachment on biomaterials and increase the quantity and uniformity of bone and vasculature 
formation in vivo. Findings validate phage display as a new technology platform to engineer the 
interface between selective cell populations and specific biomaterial chemistries.  
 
 
 
 
